Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta

  • Home
  • India
  • Delhi
  • Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta

Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta To know more..like this page...and learn more about the treatment.

As per american guidelines, medical treatment alone is very much possible for heart vessel blockage or blockage in heart without need for angioplasty/bypass surgery. Many clinical studies have proved that angioplasty/bypass surgery gives no benefit compared to medical treatment in many patients of blockage in heart & its results are almost equal to that of medical treatment or sometimes even inferior to that of medical treatment. This is the only reason american heart association & american college of cardiology have made some guidelines in favour of medical treatment which every doctor should follow.Due to these guidelines only recently in america angioplasty/bypass surgery have been reduced to the tune of 40% which is a remarkable figure.

07/12/2025

!! In heart attack after 24 hrs, if no chest pain then no role of angioplasty, only medical treatment is recommended as per american guidelines !!

06/12/2025

!! Even one cigarette a day or less increases death risk by 64 percent !!

Most people would agree that smoking is harmful, but many of us think smoking just a little bit is not that dangerous. New research suggests there is no such thing as safe smoking, with low-intensity smoking significantly increasing the risk of premature death.

New study investigates the harm in smoking as little as one cigarette a day.

With the help of public awareness campaigns, the negative health effects of smoking have become widely acknowledged.

Smoking causes a variety of diseases affecting almost every organ in the human body, making it the leading cause of death worldwide.

The Centers for Disease Control and Prevention (CDC) report that every year almost 6 million people die from a smoking-related disease, and in the United States alone, smoking accounts for 480,000 yearly deaths.

While most people will be convinced of the harmful effects of heavy smoking, not as many are aware that even an average of one cigarette a day may cause significant damage to our health.

A new study investigates the health risks involved in low-intensity smoking.

Studying the risk of early death in low-intensity smokers

Researchers from the National Cancer Institute (NCI) analyzed over 290,000 adults in the NIH-AARP Diet and Health Study.

The team - led by Maki Inoue-Choi, Ph.D., Division of Cancer Epidemiology and Genetics from the NCI - defined low-intensity smoking as 10 or fewer ci******es per day. Study participants were between 59 and 82 years old at the beginning of the study.

Participants were asked to report on their lifetime smoking patterns. Questions were divided over nine periods of the participants' life, ranging from before their 15th birthday to after the age of 70.

Of those who were current smokers, 159 reported smoking less than one cigarette per day throughout their smoking years. Almost 1,500 said they smoked between one and 10 ci******es every day.

The results of the study were published in the journal JAMA Internal Medicine.

One cigarette a day or less increases death risk by 64 percent

The study revealed that even low-intensity smoking could pose serious health risks.

People who consistently smoked as little as one cigarette a day throughout their lives were still 64 percent more likely to die earlier than never smokers.

Those who smoked between one and 10 ci******es a day had an 87 percent higher risk of dying earlier than never smokers.

Among former smokers, the risk of dying earlier was lower among those who used to be low-intensity smokers compared with those who were still smokers. The risk of premature death also decreased proportionally with the age when these smokers quit.

The research also revealed some interesting trends in specific causes of death. Researchers noticed a strong association with lung cancer.

Those who smoked an average of less than one cigarette per day over their lifetime were nine times more likely to die from lung cancer than non-smokers.

Additionally, those who smoked between one and 10 ci******es a day had a 12 times higher risk of dying from lung cancer than never smokers.

Low-intensity smokers had a six times higher risk of developing respiratory diseases such asemphysema than never smokers. They were also almost one and a half times likelier to die of cardiovascular disease than non-smokers.

Study reinforces 'no safe level of smoking' health warnings

The overall negative health effects of smoking are well known, and public awareness of the risks has led to a ban on smoking in public places.

A historical analysis of public awareness reveals that between 1949 and 1981, the proportion of smokers who believe smoking to be harmful rose from 0.52 in 1949 to 0.81 in 1981.

However, many smokers continue to think that smoking a small number of ci******es every day does not pose any health risks at all.

In fact, a recent study of over 1,600 French smokers and non-smokers revealed that over 34 percent of the respondents think up to 10 ci******es a day does not increase the risk of lung cancer.

In this context, the NCI study is a much-needed reminder that even smoking a small number of ci******es is significantly harmful to one's health.

"The results of this study support health warnings that there is no safe level of exposure to to***co smoke. Together, these findings indicate that smoking even a small number of ci******es per day has substantial negative health effects and provide further evidence that smoking cessation benefits all smokers, regardless of how few ci******es they smoke."

Maki Inoue-Choi, lead author of the study

Strengths and limitations of the study

As the study relied on the participants' ability to self-report, the findings are more susceptible to recall bias, making the results less certain.

Additionally, while the study sample was in itself large, the actual number of low-intensity smokers who had been consistent over their lifetime was small.

Also, participants were predominantly white and in their 60s and 70s, which limits the findings to a particular age and racial group of Americans.

The authors point out that historically, low-intensity smoking has been associated with minorities in the U.S., so future studies would need to focus on other racial and ethnic groups, as well as on younger participants.

The scientists also lacked data on more detailed smoking patterns, such as the smoking frequency among low-intensity smokers. Therefore, they could not examine whether smoking every other day, every few days, or weekly had a significant impact on health risks.

04/12/2025

!! Smoking is the single largest cause of preventable death. 30% cancer deaths & 20% heart disease deaths are directly attributable to smoking !!

02/12/2025

As per american guidelines, medical treatment alone is very much possible for heart blockage without need for angioplasty/bypass surgery.

28/11/2025

!! Stent Surgery Outcomes Worse in Heart Patients with Diabetes - a recent study !!

“A recent study from Karolinska Institute in Sweden, published in Diabetes Care november 2025 reported that patients with diabetes had a higher risk of complications following stent implantation.”

A recent study from Karolinska Institute in Sweden, published in Diabetes Care, examined the impact of diabetes on the risk of complications after stent implantation

The investigation included data from more than 160,000 individuals who received drug-eluting stents between 2010 and 2020. These stents are placed in the coronary arteries and slowly release medication to prevent the vessel from narrowing again. Patients were divided into three groups: type 1 diabetes, type 2 diabetes, and no diabetes.

Results showed that patients with type 1 diabetes had more than twice the risk of stent-related complications compared with patients without diabetes. Individuals with type 2 diabetes also had an increased risk, although the elevation was less pronounced. Reported complications included in-stent restenosis, where the artery narrows again, and stent thrombosis, involving clot formation within the stent.

The highest risk was observed during the first months following the procedure. In the first month, the incidence reached 9.27 per 100 person-years among patients with type 1 diabetes, compared with 4.34 in those without diabetes. Although the risk declined after six months, it remained higher in both diabetes groups.

The findings highlighted the need for individualized treatment and enhanced follow-up in patients with diabetes after stent implantation to better address their increased complication risk.

27/11/2025

Mindfulness meditation

Sit on a straight–backed chair or cross–legged on the floor.
Focus on an aspect of your breathing, such as the sensation of air flowing into your nostrils and out of your mouth, or your belly rising and falling as you inhale and exhale.

Once you have narrowed your concentration in this way, begin to widen your focus. Become aware of sounds, sensations and ideas.

Embrace and consider each thought or sensation without judging it good or bad. If your mind starts to race, return your focus to your breathing. Then expand your awareness again.

27/11/2025

!! WHO declares loneliness a global health crisis, comparable to smoking 15 ci******es !!

The World Health organization has designated loneliness as a significant worldwide health concern, equating its mortality impact to smoking 15 ci******es a day, according to the US surgeon general. Launching an international commission on loneliness, led by Dr. Vivek Murthy and Chido Mpemba, the WHO aims to address the pressing issue that transcends borders, impacting health, well-being, and development globally. The three-year commission follows heightened loneliness levels during the COVID-19 pandemic, shedding light on the critical role of social connection. Loneliness poses health risks surpassing those linked to obesity and physical inactivity, with older adults facing increased dementia and cardiovascular disease risks. Not confined to developed nations, loneliness affects one in four older individuals worldwide. Youth, particularly in Africa, also grapple with loneliness, impacting education, job satisfaction, and economic outcomes. The WHO emphasizes the urgency of recognizing loneliness as a pervasive public health threat requiring global attention. (The Guardian. 16 November 2023)

23/11/2025

!! The song of Cardio Pulmonary Resuscitation (CPR) .. explains the whole procedure & how to save a Life, in case of emergency !!

21/11/2025

!! No Late Benefit From Early Angioplasty in Stable Heart Disease - Courage Study !!

No need of angioplasty if your symptoms like chest pain or breathlessness are stable & not progressing over time. Medical treatment alone is possible & recommended as per American guidelines (AHA/AHC) even in patients having 90-100% blockage of two or three vessels

17/11/2025

!! Dialysis Not Always Best Option in Advanced Kidney Disease, Conservative Management Is an Alternative Approach !!
- American Society of Nephrology

Hospitalization rates were higher in patients with advanced chronic kidney disease (CKD) treated with dialysis than those treated with conservative management, among those with an estimated glomerular filtration rate (eGFR) < 25 mL/min/1.73m2 and in most racial/ethnic groups, new research shows.

Patients mostly start dialysis because of unpleasant symptoms that cause suffering including high potassium levels and high levels of uremic toxins in the blood.
"Conservative management serves to address and manage these symptoms and levels of toxicities without dialysis, so conservative management is an alternative approach and patients should always be given a choice between [the two]," stressed Kalantar-Zadeh, professor of medicine at the University of California, Irvine.
The results were presented during Kidney Week 2022.
"There has been growing recognition of the importance of conservative nondialytic management as an alternative patient-centered treatment strategy for advanced kidney disease. However, conservative management remains under-utilized in the United States, which may in part be due to uncertainties regarding which patients will most benefit from dialysis versus nondialytic treatment," said first author Connie Rhee, MD, also of the University of California, Irvine.

"We hope that these findings and further research can help inform treatment options for patients, care partners, and providers in the shared decision-making process of conservative management versus dialysis," added Rhee, in a press release from the American Society of Nephrology.
Asked for comment, Sarah Davison, MD, noted that part of the Society's strategy is, in fact, to promote conservative kidney management (CKM) as a key component of integrated care for patients with kidney failure. Davison is professor of medicine and chair of the International Society Working Group for Kidney Supportive Care and Conservative Kidney Management.
"We've recognized for a long time that there are many patients for whom dialysis provides neither a survival advantage nor a quality of life advantage," she told Medscape Medical News.
"These patients tend to be those who have multiple morbidities, who are more frail, and who tend to be older, and in fact, the patients can live as long, if not longer, with better symptom management and better quality of life by not being on dialysis," she stressed.
Study Details

In the study, using data from the Optum Labs Data Warehouse, patients with advanced CKD were categorized according to whether or not they received conservative management, defined as those who did not receive dialysis within 2 years of the index eGFR (first eGFR < 25 mL/min/1.73m2), versus receipt of dialysis parsed as late versus early dialysis transition (eGFR < 15 vs ≥ 15 mL/min/1.73m2 at dialysis initiation).
Hospitalization rates were compared between those treated with conservative management compared with late or early dialysis.
"Among 309,188 advanced CKD patients who met eligibility [criteria], 55% of patients had ≥ 1 hospitalization(s) within 2 years of the index eGFR," the authors report. The most common causes of hospitalization among all patients were congestive heart failure, respiratory symptoms, or hypertension.
In most racial groups (non-Hispanic White, non-Hispanic Black, and Hispanic patients), patients on dialysis had higher hospitalization rates than those who received conservative management, and patients who started dialysis early (transitioned to dialysis at higher levels of kidney function) demonstrated the highest rates across all age groups compared with those who started dialysis late (transitioned to dialysis at lower levels of kidney function) or were treated with conservative management.
Among Asian patients, those on dialysis also had higher hospitalization rates than those receiving conservative management, but patients who started dialysis late had higher rates than those on early dialysis, especially in older age groups, possibly because they were sicker, Kalantar-Zadeh suggested.
Conservative Care Has Pros and Cons, but Canada Has Embraced it

As Kalantar-Zadeh explained, conservative management has its pros and cons compared with dialysis. "Conservative management requires that patients work with the multidisciplinary team including nephrologists, nutritionists, and others to try to manage CKD without dialysis, so it requires patient participation."
On the other hand, dialysis is both easier and more lucrative than conservative management, at least for nephrologists, as they are well-trained in dialysis care and it can be systematically applied. As to which patients with CKD might be optimal candidates for conservative management, Kalantar-Zadeh agreed this requires further study.
But he acknowledged that most nephrologists are not hugely supportive of conservative management because they are less well-trained in it and it is more time-consuming. The one promising change is a new model introduced in 2022, a value-based kidney care model, that if implemented will be more incentivizing for nephrologists to offer conservative care more widely.
Davison meanwhile believes the "vast majority" of nephrologists based in Canada — as she is — are "highly supportive" of CKM as an important modality.
"The challenge, however, is that many nephrologists remain unsure as to how to best deliver or optimize all aspects of CKM whether that is symptom management, advanced care planning, or how they must manage symptoms to align with a patient's goals," Davison explained.
"But it's not that they do not believe in the value of CKM."
Indeed, in her province, Alberta, nephrologists have been offering CKM for decades, and while they are currently standardizing care to make it easier to deliver, there is no financial incentive to offer dialysis over CKM.
"We are now seeing those elements of kidney supportive care as part of core competencies to manage any person with chronic illness including CKD," Davison said.
"So it's absolutely doable and contrary to one of the myths about CKM, it is not more time-consuming than dialysis — not when you know how to do it, you are just shifting your focus," she emphasized.

06/11/2025

!! Coronary stenting does not benefit patients with severe left ventricular dysfunction !!
REVIVED-BCIS2 trial

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalisation in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research.

Coronary artery disease is the most common cause of heart failure and is associated with poor survival and low quality of life despite advances in medical therapy. Treating the coronary arteries to improve blood supply (revascularisation) has long been considered as a treatment option in this population. In the STICH trial, coronary artery bypass surgery improved survival but only in highly selected, typically young, patients. However, the benefit took 10 years to emerge, largely due to the early harm of the operation. PCI was an attractive alternative to bypass surgery, as it might offer the benefits of revascularisation without the early hazard. However, there was no randomised evidence to support this and guidelines recommending the use of this treatment in some patients were based only on expert opinion.

REVIVED-BCIS2 is the first adequately powered randomised trial to examine the efficacy and safety of PCI in patients with left ventricular systolic dysfunction.5 The trial enrolled patients with severe left ventricular dysfunction (ejection fraction 35% or below), extensive coronary artery disease and demonstrable viability in at least four dysfunctional myocardial segments that could be revascularised by PCI. Viability could be assessed by any modality, but cardiac magnetic resonance imaging was used most. Those with a myocardial infarction within four weeks, decompensated heart failure or sustained ventricular arrhythmias within 72 hours were excluded.

A total of 700 patients from 40 centres in the UK were randomly assigned in a 1:1 ratio to either PCI with optimal medical therapy or optimal medical therapy alone. The median age of participants was 70 years, 88% were men and the mean left ventricular ejection fraction was 28%. The primary outcome was the composite of all-cause death or hospitalisation for heart failure. Secondary outcomes included left ventricular ejection fraction at six and 12 months and quality of life measures.

During a median follow up of 3.4 years, the primary outcome occurred in 129 (37.2%) patients in the PCI group and 134 (38.0%) patients in the medical therapy alone group for a hazard ratio of 0.99 (95% confidence interval 0.78–1.27, p=0.96).

Chief Investigator Professor Divaka Perera of King’s College London, UK said: “PCI provided no incremental benefit over optimal medical therapy, in this high-risk population, where approximately one in three patients died or were hospitalised with heart failure during follow-up.”

No significant difference was seen between groups in the major secondary outcome of the trial, left ventricular ejection fraction at six and 12 months. Given that only patients with demonstrable myocardial viability were enrolled, the latter finding challenges the concept of myocardial hibernation, which for decades has been considered an adaptation of the heart to cope with the effects of severe coronary disease, that can be reversed by treating the coronary disease.

Quality of life (the other major secondary outcome) favoured PCI at six and 12 months but there was no difference between groups at 24 months.

Professor Perera said: “We can conclude that PCI should not be offered to stable patients with ischaemic left ventricular dysfunction if the sole aim is to provide prognostic benefit. Our findings were consistent across all subgroups and for all prespecified outcome measures. These definitive results should help to rationalise guidelines on managing coronary disease in patients with very poor left ventricular function. However, it is important to note that REVIVED-BCIS2 excluded patients with limiting angina or recent acute coronary syndromes, and PCI is still an option in these contexts.”

26/10/2025

In Normal Coronary Angiography - Still Chest Pain May Be Related To Heart........Correlation of Symptoms & Non Invasive Tests More Important......Cardiac Syndrome X

Cardiac syndrome X ; is clinical syndrome with the following characteristics:

●Angina or angina-like chest pain with exertion.
●Electrocardiographic evidence of ST segment depression on treadmill exercise testing.
●Normal coronary angiography, with no spontaneous or inducible epicardial coronary artery spasm on ergonovine or acetylcholine provocation, such as that seen with variant angina. the term “cardiac syndrome X” is occasionally confused with “metabolic syndrome X” which refers to the constellation of insulin resistance, obesity, hypertension, diabetes, and dyslipidemia. PATHOGENESIS — The pathogenesis of cardiac syndrome X is uncertain. Two mechanisms that are not mutually exclusive have been proposed: myocardial ischemia that might be caused by coronary microvascular dysfunction (ie, abnormal dilatory responses and/or increased vasoconstriction); and enhanced sensitivity to intracardiac pain or the so-called "sensitive heart" syndrome
Response to nitroglycerin — Many undiagnosed patients with anginal type chest pain are given sublingual nitroglycerin both as a diagnostic test and to relieve symptoms due to angina. In cardiac syndrome X, as the small arterioles as less directly affected by the vasodilatory effects of nitroglycerin compared to the epicardial arteries, the drug may not be reliably effective.

Noninvasive testing — The typical finding on the exercise ECG is horizontal or downsloping ST segment depression, as seen in patients with obstructive coronary artery disease.

Most patients will undergo nuclear stress testing. Exercise thallium-201 myocardial scintigraphy may demonstrate regional myocardial perfusion defects during exercise . However, some reports have demonstrated neither perfusion defects nor regional wall motion abnormalities after dobutamine or transesophageal atrial pacing, despite the frequent provocation of chest pain . It is possible that ischemia is limited to the subendocardium, which could explain the absence of wall motion abnormalities as assessed by echocardiography
Cardiac magnetic resonance — It is able to detect regional differences in myocardial blood flow.

Coronary angiography — A coronary angiogram showing normal epicardial coronary arteries (

Address

485, Kohat Enclave, Pitampura
Delhi
110034

Alerts

Be the first to know and let us send you an email when Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category